Characteristics | Intervention group (n = 28) | Placebo group (n = 28) | P-value |
---|---|---|---|
Demographics and anthropometric parameters | |||
Age (years) | 40.64 ± 8.39 | 40.61 ± 9.14 | 0.988a |
Male gender, number (%) | 12(42.9) | 14(50) | 0.789b |
Family history of diabetes, number (%) | 11(39.3) | 8(28.6) | 0.573b |
Body weight (kg) | 81.56 ± 16.14 | 87.88 ± 19.92 | 0.198a |
BMI (kg/m2) | 30.89 ± 5.76 | 32.48 ± 7.57 | 0.380a |
Waist circumference (cm) | |||
Male | 102.46 ± 14.65 | 102.43 ± 12.64 | 0.996a |
Female | 89.75 ± 7.1 | 93.36 ± 11.06 | 0.291a |
Waist/hip ratio | 0.87 ± 0.09 | 0.87 ± 0.06 | 0.828a |
Current smoking, number (%) | 2(7.1) | 3(10.7) | 1.000b |
Current alcohol use, number (%) | 3(10.7) | 7(25) | 0.295b |
Underlying disease, number (%) | |||
Dyslipidemia | 4(14.3) | 5(17.9) | 1.000b |
Hypertension | 4(14.3) | 8(28.6) | 0.329b |
Others | 5(17.9) | 7(25) | 0.746b |
Metabolic and other biochemical parameters | |||
FPG (mg/dL) | 94.68 ± 11.21 | 92.5 ± 10.21 | 0.451a |
HbA1C (%) | 6.03 ± 0.16 | 5.96 ± 0.13 | 0.064a |
2 h-PG (mg/dL) | 143.5 ± 30.21 | 148.64 ± 26.12 | 0.499a |
Total cholesterol (mg/dL) | 201.71 ± 31.3 | 206.82 ± 54.75 | 0.910a |
HDL cholesterol (mg/dL) | 50.93 ± 7.12 | 48.11 ± 10.59 | 0.247a |
LDL cholesterol (mg/dL) | 129.68 ± 31.6 | 139.71 ± 39.53 | 0.299a |
Triglyceride (mg/dL) | 142.5 ± 86.6 | 134.61 ± 89.39 | 0.738a |
Physical activity | |||
Moderate-to-vigorous activity (METs) | 0 (0-1140) | 0 (0-1650) | 0.898c |
Sedentary time (hours/day) | 2.36 ± 3.9 | 2.09 ± 2.38 | 0.757a |